Jörg Schmidtke – författare
Visar alla böcker från författaren . Handla med fri frakt och snabb leverans.
3 produkter
3 produkter
Häftad, Tyska, 2003
561 kr
Skickas inom 10-15 vardagar
Entwicklungen in Biomedizin, Genetik und Informatik führen zu einem Wissenszuwachs im Verständnis der Ursachen und Entstehungsmechanismen von Krankheiten. Damit verbunden ist die Hoffnung, zukünftig Krankheitsrisiken frühzeitiger zu erkennen und durch Maßnahmen der Entwicklung von Krankheiten vorzubeugen. Mehr als andere Untersuchungsergebnisse erlauben genetische Informationen Aussagen über den Gesundheitszustand auch von Familienangehörigen. Sie bergen damit das Risiko konfligierender Interessen im Hinblick auf deren autonome Lebensführung und informationelle Selbstbestimmung in sich. Das Buch enthält die auf dem 10. Einbecker Workshop gehaltenen Vorträge, die sich aus medizinisch-naturwissenschaftlicher und juristischer Sicht mit dem Thema befassen. Im Anhang werden wichtige Materialien zum Thema Gentest ergänzt. So ist das österreichische Gentechnikgesetz, der Schweizer Entwurf eines Gentestgesetzes und der Entwurf der Fraktion der GRÜNEN im Bundestag für ein Deutsches Gentestgesetz enthalten.
Inbunden, Engelska, 2010
2 224 kr
Skickas inom 10-15 vardagar
Initially genetic disorders were all considered as rare diseases. At present, in the mid of 2009, the OMIM catalogue contains information on more than 12 000 entries of which about 2500 are available for clinical testing based on the identification of the responsible gene defect. However, altogether it has been estimated that about 8 percent of a population in the economically developed countries will during their lifetime suffer from a disease mainly as the result of their genetic constitution. Adding to that, it is estimated that all diseases have a genetic component, which will determine who will be at a higher than average risk for a certain disorder. Further it is postulated that in the near future, this genetic profiling could become useful in selecting an appropriate therapy adapted to the genetic constitution of the person. Thus, genetic disorders are not rare.Measuring quality of health care related processes became an issue in the 1990s, mainly in laboratory medicine, but also for hospitals and other health care systems. In many countries national authorities started to implement recommendations, guidelines or legal procedures regulating quality of health care delivery. In laboratory medicine, in parallel, the use of accreditation as a method assuring high quality standards in testing came in use. With the increasing possibilities of performing molecular genetic testing, genetic laboratories needed to become involved in this process.As many genetic disorders are rare, most laboratories worldwide offered analysis for a specific set of disorders, and, therefore, very early on a transborder flow of samples occurred. While international quality criteria (ISO) have been in existence for a number of years, the regulation of quality issues still may differ between countries. Based on their personal experience in the varying fields of quality research and clinical implementation of quality criteria in genetic services the authors of thisbook share their experience and give examples of the implementation of quality issues in national quality systems worldwide. This book, which is the result of the effort of many persons, is destined to aid laboratory managers and counsellors, health care managers and other stakeholders in national or international health care service to improve the services to the benefit of patients with suspected genetic disorders.
Häftad, Engelska, 2014
2 224 kr
Skickas inom 10-15 vardagar
Initially genetic disorders were all considered as rare diseases. At present, in the mid of 2009, the OMIM catalogue contains information on more than 12 000 entries of which about 2500 are available for clinical testing based on the identification of the responsible gene defect. However, altogether it has been estimated that about 8 percent of a population in the economically developed countries will during their lifetime suffer from a disease mainly as the result of their genetic constitution. Adding to that, it is estimated that all diseases have a genetic component, which will determine who will be at a higher than average risk for a certain disorder. Further it is postulated that in the near future, this genetic profiling could become useful in selecting an appropriate therapy adapted to the genetic constitution of the person. Thus, genetic disorders are not rare.Measuring quality of health care related processes became an issue in the 1990s, mainly in laboratory medicine, but also for hospitals and other health care systems. In many countries national authorities started to implement recommendations, guidelines or legal procedures regulating quality of health care delivery. In laboratory medicine, in parallel, the use of accreditation as a method assuring high quality standards in testing came in use. With the increasing possibilities of performing molecular genetic testing, genetic laboratories needed to become involved in this process.As many genetic disorders are rare, most laboratories worldwide offered analysis for a specific set of disorders, and, therefore, very early on a transborder flow of samples occurred. While international quality criteria (ISO) have been in existence for a number of years, the regulation of quality issues still may differ between countries. Based on their personal experience in the varying fields of quality research and clinical implementation of quality criteria in genetic services the authors of thisbook share their experience and give examples of the implementation of quality issues in national quality systems worldwide. This book, which is the result of the effort of many persons, is destined to aid laboratory managers and counsellors, health care managers and other stakeholders in national or international health care service to improve the services to the benefit of patients with suspected genetic disorders.